Business Wire
Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study
📈
AI Sentiment
Highly Positive
8/10
Janux Therapeutics Inc. News
Latest updates and market news for JANX
1 news
Dec 21 - Dec 27, 2025
Page 1
Share this news page